文献速递肝病

人肝细胞移植中的宿主预处理与排斥监测

Host conditioning and rejection monitoring in hepatocyte transplantation in humans.
PubMed 文献 · J Hepatol · 2016-12-24

该研究先在非人灵长类中验证肝定向放疗可改善供体肝细胞植入,随后在遗传性肝病患者中应用放疗预处理联合T细胞免疫监测进行肝细胞移植。一例经典苯丙酮尿症患者移植后血苯丙氨酸从1343±48μM降至854±25μM(下降36%,p<0.0001),但随访不规律后发生移植物丢失。

要点

  • 非人灵长类中10Gy肝定向照射后猪肝细胞植入并扩增至照射肝段的15%。
  • 两例尿素循环障碍患者肝细胞移植后早期移植物丢失,回顾性免疫监测提示需加强免疫抑制。
  • 苯丙酮尿症患者移植后血苯丙氨酸下降36%(p<0.0001),但随访不规律后移植物丢失。

核心结论

  • 放疗预处理和连续排斥风险评估可能改善移植肝细胞的植入和长期存活。
  • 肝细胞异种移植在非人灵长类中可植入数月,可能为急性肝衰竭患者提供有效治疗。

研究设计与样本

  • 先在非人灵长类中检验肝定向放疗改善供体肝细胞植入的策略,随后应用于人类受试者。
  • 在人类受试者中进行T细胞免疫监测以评估免疫抑制是否充分。
  • 一例27岁女性经典苯丙酮尿症患者接受放疗预处理、抗淋巴细胞诱导和频繁免疫监测下的肝细胞移植。

主要发现

  • 猪肝细胞移植在经10Gy肝定向照射预处理的免疫抑制猴中植入并扩增至照射肝段的15%。
  • 两例尿素循环缺陷患者肝细胞移植后早期移植物丢失,回顾性免疫监测提示需要额外免疫抑制。
  • 苯丙酮尿症患者移植后肝活检显示多个移植细胞小簇、多个核分裂象和Ki67+肝细胞。
  • 移植后平均外周血苯丙氨酸从移植前1343±48μM(正常30-119μM)降至854±25μM(治疗目标≤360μM),下降36%,p<0.0001,尽管仅移植了目标供体肝细胞数的一半。
  • 随访期间苯丙氨酸水平保持在900μM以下,但随访不规律后发生移植物丢失。

关键数值与推荐

  • 非人灵长类预处理采用10Gy肝定向照射。
  • 苯丙酮尿症患者移植前血苯丙氨酸1343±48μM,正常范围30-119μM,治疗目标≤360μM。
  • 移植后平均血苯丙氨酸854±25μM,较移植前下降36%,p<0.0001。

临床怎么用

  • 作者认为放疗预处理和连续排斥风险评估可能产生更好的植入和长期存活。
  • 作者认为肝细胞异种移植在非人灵长类中植入数月,可能为急性肝衰竭患者提供有效治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hepatocyte transplantation partially corrects genetic disorders and has been associated anecdotally with reversal of acute liver failure. Monitoring for graft function and rejection has been difficult, and has contributed to limited graft survival. Here we aimed to use preparative liver-directed radiation therapy, and continuous monitoring for possible rejection in an attempt to overcome these limitations. METHODS: Preparative hepatic irradiation was examined in non-human primates as a strategy to improve engraftment of donor hepatocytes, and was then applied in human subjects. T cell immune monitoring was also examined in human subjects to assess adequacy of immunosuppression. RESULTS: Porcine hepatocyte transplants engrafted and expanded to comprise up to 15% of irradiated segments in immunosuppressed monkeys preconditioned with 10Gy liver-directed irradiation. Two patients with urea cycle deficiencies had early graft loss following hepatocyte transplantation; retrospective immune monitoring suggested the need for additional immunosuppression. Preparative radiation, anti-lymphocyte induction, and frequent immune monitoring were instituted for hepatocyte transplantation in a 27year old female with classical phenylketonuria. Post-transplant liver biopsies demonstrated multiple small clusters of transplanted cells, multiple mitoses, and Ki67+ hepatocytes. Mean peripheral blood phenylalanine (PHE) level fell from pre-transplant levels of 1343±48μM (normal 30-119μM) to 854±25μM (treatment goal ≤360μM) after transplant (36% decrease; p<0.0001), despite transplantation of only half the target number of donor hepatocytes. PHE levels remained below 900μM during supervised follow-up, but graft loss occurred after follow-up became inconsistent. CONCLUSIONS: Radiation preconditioning and serial rejection risk assessment may produce better engraftment and long-term survival of transplanted hepatocytes. Hepatocyte xenografts engraft for a period of months in non-human primates and may provide effective therapy for patients with acute liver failure. LAY SUMMARY: Hepatocyte transplantation can potentially be used to treat genetic liver disorders but its application in clinical practice has been impeded by inefficient hepatocyte engraftment and the inability to monitor rejection of transplanted liver cells. In this study, we first show in non-human primates that pretreatment of the host liver with radiation improves the engraftment of transplanted liver cells. We then used this knowledge in a series of clinical hepatocyte transplants in patients with genetic liver disorders to show that radiation pretreatment and rejection risk monitoring are safe and, if optimized, could improve engraftment and long-term survival of transplanted hepatocytes in patients.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Soltys KA, Setoyama K, Tafaleng EN, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2016. PMID: 28027971. doi:10.1016/j.jhep.2016.12.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。